{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:09:56Z","timestamp":1793761796002,"version":"4.6.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.drugalcdep.2018.04.025","type":"journal-article","created":{"date-parts":[[2018,5,29]],"date-time":"2018-05-29T12:51:16Z","timestamp":1527598276000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors"],"prefix":"10.1016","volume":"189","author":[{"given":"Anat","family":"Sason","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Adelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaul","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7091-7987","authenticated-orcid":false,"given":"Einat","family":"Peles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.drugalcdep.2017.01.013","article-title":"Benzodiazepine, z-drug and pregabalin prescriptions and mortality among patients in opioid maintenance treatment-a nation-wide register-based open cohort study","volume":"174","author":"Abrahamsson","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1080\/10826084.2017.1298619","article-title":"Characteristics and outcome of male and female methadone maintenance patients: MMT in Tel Aviv and Las Vegas","volume":"53","author":"Adelson","year":"2018","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/15569527.2016.1141420","article-title":"Unilateral hemorrhagic macular infarction associated with marijuana, alcohol and antiepileptic drug intake","volume":"36","author":"Akta\u015f","year":"2017","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0020","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000355268","article-title":"Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers","volume":"20","author":"Baird","year":"2014","journal-title":"Eur. Addict. Res."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.2165\/11536200-000000000-00000","article-title":"A comparison of the pharmacokinetics and pharmacodynamics of pregabalin and gabapentin","volume":"49","author":"Bockbrader","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0030","first-page":"82","article-title":"On the risk of dependence on gabapentinoids","volume":"86","author":"Bonnet","year":"2018","journal-title":"Fortschr. Neurol. Psychiatr."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s40261-017-0616-y","article-title":"Intentional drug overdose involving pregabalin and gabapentin: findings from the National Self-Harm Registry Ireland, 2007\u20132015","volume":"38","author":"Daly","year":"2018","journal-title":"Clin. Drug. Invest."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.drugalcdep.2015.10.018","article-title":"Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients","volume":"157","author":"Dunn","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0045","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrd1756","article-title":"Pregabalin","volume":"4","author":"Dworkin","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0050","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/1556-4029.13263","article-title":"Determining the toxicological significance of pregabalin in fatalities","volume":"62","author":"Elliott","year":"2017","journal-title":"J. Forensic. Sci."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0055","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s40265-017-0700-x","article-title":"Abuse and misuse of pregabalin and gabapentin","volume":"77","author":"Evoy","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0060","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s40263-014-0192-0","article-title":"Pregabalin: a review of its use in adults with generalized anxiety disorder","volume":"28","author":"Frampton","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0065","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1007\/s00228-013-1578-5","article-title":"Pregabalin abuse among opiate addicted patients","volume":"69","author":"Grosshans","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0070","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0075","first-page":"30","article-title":"Analytical methodology","volume":"73","author":"Hawks","year":"1986","journal-title":"NIDA Res. Monogr."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/hup.2512","article-title":"New psychoactive substances as part of polydrug abuse within opioid maintenance treatment revealed by comprehensive high-resolution mass spectrometric urine drug screening","volume":"31","author":"Heikman","year":"2016","journal-title":"Hum. Psychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0085","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1080\/03610928008827941","article-title":"A goodness-of-fit test for the multiple logistic regression model","volume":"A10","author":"Hosmer","year":"1980","journal-title":"Commun. Stat."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0090","article-title":"GC-MS\/MS detects potential pregabalin abuse in susceptible subjects\u2019 hair","author":"Ianni","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0095","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jamainternmed.2017.7856","article-title":"Gabapentinoid use in the United States 2002 through 2015","volume":"178","author":"Johansen","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0100","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1055\/s-0032-1305042","article-title":"Pregabalin for the reduction of opiate withdrawal symptoms","volume":"39","author":"K\u00e4mmerer","year":"2012","journal-title":"Psychiatr. Prax."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.17116\/jnevro20161167129-36","article-title":"A randomized single-blind study of the efficacy of pregabalin in the treatment of opioid withdrawal syndrome","volume":"116","author":"Krupitsky","year":"2016","journal-title":"Zh. Nevrol. Psikhiatr. Im. S. S. Korsakova"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0110","first-page":"309","article-title":"Pregabalin abuse amongst opioid substitution treatment patients","volume":"108","author":"McNamara","year":"2015","journal-title":"Ir. Med. J."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0115","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol. Rep."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0120","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.pain.2004.11.011","article-title":"Significantly higher methadone dose for methadone maintenance treatment (MMT) patients with chronic pain","volume":"113","author":"Peles","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0125","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.euroneuro.2007.10.001","article-title":"Tricyclic antidepressants abuse, with or without benzodiazepines abuse, in former heroin addicts currently in methadone maintenance treatment (MMT)","volume":"18","author":"Peles","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0130","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jsat.2014.12.010","article-title":"Differences in methylphenidate abuse rates among methadone maintenance treatment patients in two clinics","volume":"54","author":"Peles","year":"2015","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0135","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2017.11.034","article-title":"Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center","volume":"185","author":"Peles","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0140","first-page":"28","article-title":"Needs assessment and treatment compliance at state opioid substitution treatment programs in Georgia","volume":"214","author":"Piralishvili","year":"2013","journal-title":"Georgian Med. News"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0145","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40263-014-0164-4","article-title":"Misuse and abuse of pregabalin and gabapentin: cause for concern?","volume":"28","author":"Schifano","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0150","doi-asserted-by":"crossref","first-page":"f6747","DOI":"10.1136\/bmj.f6747","article-title":"Bad medicine: gabapentin and pregabalin","volume":"347","author":"Spence","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.drugalcdep.2018.04.025_bib0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/dta.1818","article-title":"Patterns of drug abuse among drug users with regular and irregular attendance for treatment as detected by comprehensive UHPLC-HR-TOF-MS","volume":"8","author":"Sundstr\u00f6m","year":"2016","journal-title":"Drug Test. Anal."}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871618302916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:54:14Z","timestamp":1759827254000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871618302916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":31,"alternative-id":["S0376871618302916"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.025","relation":{},"ISSN":["0376-8716"],"issn-type":[{"value":"0376-8716","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pregabalin misuse in methadone maintenance treatment patients in Israel: Prevalence and risk factors","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}